Europe - Euronext Paris - EPA:BLC - FR0000035370 - Common Stock
The current stock price of BLC.PA is 25.5 EUR. In the past month the price increased by 4.51%. In the past year, price increased by 8.05%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AXNA.DE | AMPLIFON SPA | 25.66 | 3.08B | ||
| AMP.MI | AMPLIFON SPA | 25.6 | 3.07B | ||
| FAGR.BR | FAGRON | 18.89 | 1.63B | ||
| UPR.I | UNIPHAR PLC | 16.45 | 939.64M | ||
| ILM1.DE | MEDIOS AG | 17.7 | 392.85M | ||
| VMED.DE | VIROMED MEDICAL AG | N/A | 83.03M |
Bastide Le Confort Médical SA is engaged in the provision and rental of medical supplies and equipment for elderly, sick and handicapped people, and healthcare professionals. The company is headquartered in Caissargues, Occitanie and currently employs 3,685 full-time employees. The firm activity is organized around three families of products and services such as home care equipment and services, respiratory assistance equipment and services, perfusion and nutrition equipment and services, It provides hospital beds, personal assistance products, etc. The firm provides mainly respirators, oxygen concentrators, and oxygen tanks; The offers perfusion, nutrition, and insulin pumps and syringe-drivers. The company offers devices to support diabetic patients towards daily comfort and a normal life. The firm offers wide range of products and services to relieve patients losing their autonomy. The company fer tailor-made, solutions for a secure, humane, and deeply respectful care pathway.
BASTIDE LE CONFORT MEDICAL
Centre d'activite Euro 2000, 12 avenue de la Dame
Caissargues OCCITANIE FR
Employees: 3635
Phone: 33466386808
Bastide Le Confort Médical SA is engaged in the provision and rental of medical supplies and equipment for elderly, sick and handicapped people, and healthcare professionals. The company is headquartered in Caissargues, Occitanie and currently employs 3,685 full-time employees. The firm activity is organized around three families of products and services such as home care equipment and services, respiratory assistance equipment and services, perfusion and nutrition equipment and services, It provides hospital beds, personal assistance products, etc. The firm provides mainly respirators, oxygen concentrators, and oxygen tanks; The offers perfusion, nutrition, and insulin pumps and syringe-drivers. The company offers devices to support diabetic patients towards daily comfort and a normal life. The firm offers wide range of products and services to relieve patients losing their autonomy. The company fer tailor-made, solutions for a secure, humane, and deeply respectful care pathway.
The current stock price of BLC.PA is 25.5 EUR. The price increased by 4.72% in the last trading session.
BLC.PA does not pay a dividend.
BLC.PA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
The PE ratio for BASTIDE LE CONFORT MEDICAL (BLC.PA) is 364.29. This is based on the reported non-GAAP earnings per share of 0.07 and the current share price of 25.5 EUR.
BASTIDE LE CONFORT MEDICAL (BLC.PA) currently has 3635 employees.
BASTIDE LE CONFORT MEDICAL (BLC.PA) will report earnings on 2026-02-12.
ChartMill assigns a technical rating of 2 / 10 to BLC.PA. When comparing the yearly performance of all stocks, BLC.PA turns out to be only a medium performer in the overall market: it outperformed 52.72% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to BLC.PA. While BLC.PA is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months BLC.PA reported a non-GAAP Earnings per Share(EPS) of 0.07. The EPS increased by 158.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.11% | ||
| ROA | 0.08% | ||
| ROE | 0.74% | ||
| Debt/Equity | 5.31 |
6 analysts have analysed BLC.PA and the average price target is 36.72 EUR. This implies a price increase of 44% is expected in the next year compared to the current price of 25.5.
For the next year, analysts expect an EPS growth of 18.99% and a revenue growth 3.87% for BLC.PA